Institutes outside Greece
An in vitro model for the investigation of mitochondrial dynamics and quality control in Parkinson’s disease using human pluripotent stem cell-derived midbrain dopamine neurons
Abstract
dc:descriptionParkinson’s disease (PD) is a common neurodegenerative disorder characterised by severe motor and cognitive disabilities, caused by a profound loss of the midbrain dopaminergic neurons (mDANs). Although symptomatic treatment provides short-term relief, an absolute cure for PD is lacking, mainly because the aetiology of the disorder remains essentially elusive. Pathogenesis of PD has been associated with ageing, environmental and genetic factors: a common denominator being mitochondrial malfunction. Indeed, the identification of specific gene mutations associated with familial early onset PD is improving our understanding of the molecular mechanisms underlying this disease. Several of these genes mediate mitochondrial dynamics (fusion, fission, transport, mitophagy), and there is accumulating evidence that mitochondrial dysfunction is a key player in PD pathogenesis. In this respect, induced pluripotent stem cell (iPSC) technology represents an essential tool as it allows the in vitro modelling of the disease by obtaining human mDANs generated from reprogrammed adult cells derived from PD patients (e.g. dermal fibroblasts). However, insufficient quality, quantity and regional specification of the generated neurons, as well as highly heterogenic cultures could comprise the experimental outcomes, especially when investigating the sensitive to multiple factors mitochondria. This PhD aims to provide a complete in vitro model to image and monitor mitochondrial dynamics and mitochondrial quality control in mDANs that are vulnerable to PD. Following an introductory review on how mitochondrial dysfunction is related to PD, and a description of the general methods used in this study, the first result Chapter describes how combined approaches and techniques from the literature and previous in housegenerated neural differentiation methods led to the production of a suitable for mitochondrial investigation mDAN differentiation protocol. The second result Chapter presents how this protocol was further optimised to generate ~70% mDANs after 35 days of differentiation. The last result Chapter illustrates how the PSC-derived mDANs can be used to investigate mitochondrial dynamics and quality control using a variety of cell- and culture-based assessments. To conclude, this thesis presents an amenable, reproducible and expandable monolayer PSC-derived mDAN differentiation system specifically designed for the in vitro investigation of mitochondrial dynamics and quality control in PD.
Degree
thesis:*- Grantor dc:publisher
- Institutes outside Greece
- Year dc:date
- 2017
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Stathakos, Petros
- Σταθάκος, Πέτρος
Subjects
dc:subject × 22- Επαγόμενα πολυδύναμα βλαστοκύτταρα
- Νευροεκφύλιση
- Mεσεγκεφαλικοί ντοπαμινεργικοί νευρώνες
- Νόσος Πάρκινσον
- Μιτοχόνδρια
- Μιτοφαγία
- Μιτοχονδριακή δυναμική
- Αυτοφαγία
- Induced pluripotent stem cells
- Neurodegeneration
- Midbrain dopaminergic neurons
- Parkinson's disease
- Mitochondria
- Mitochondrial dynamics
- Mitophagy
- Autophagy
- Βασική Ιατρική
- Ιατρική και Επιστήμες Υγείας
- Νευροεπιστήμες
- Basic Medicine
- Medical and Health Sciences
- Neurosciences
Rights
- Language dc:language
- eng
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/61292